108554009: Guanfacine hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Adrenergic receptor agonist\Alpha adrenergic receptor agonist\Alpha-2 adrenergic receptor agonist\Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)\Guanfacine hydrochloride

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Sympathomimetic agent (substance)\Adrenergic receptor agonist\Alpha adrenergic receptor agonist\Alpha-2 adrenergic receptor agonist\Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)\Guanfacine hydrochloride

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Amidine (substance)\Guanidine and/or guanidine derivative (substance)\Guanfacine hydrochloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

173088019 Guanfacine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

602062010 Guanfacine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

25211000188118 guanfacine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

815481000172116 chlorhydrate de guanfacine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Guanfacine hydrochloride	Is a	Product containing guanfacine (medicinal product)	false	Inferred relationship	Some
Guanfacine hydrochloride	Is a	Guanfacine (substance)	false	Inferred relationship	Some
Guanfacine hydrochloride	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha-2 adrenergic receptor agonist (disposition)	false	Inferred relationship	Some
Guanfacine hydrochloride	Is a	Alpha-2 adrenergic receptor agonist	false	Inferred relationship	Some
Guanfacine hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Guanfacine (substance)	true	Inferred relationship	Some
Guanfacine hydrochloride	Is a	Substance with central alpha adrenergic receptor agonist mechanism of action	false	Inferred relationship	Some
Guanfacine hydrochloride	Is a	Guanidine and/or guanidine derivative (substance)	true	Inferred relationship	Some
Guanfacine hydrochloride	Is a	Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)	true	Inferred relationship	Some
Guanfacine hydrochloride	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Central alpha-2 adrenergic receptor agonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely guanfacine hydrochloride 1 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guanfacine hydrochloride	Inferred relationship	Some
Product containing precisely guanfacine hydrochloride 2 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guanfacine hydrochloride	Inferred relationship	Some
Product containing guanfacine hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guanfacine hydrochloride	Inferred relationship	Some
Guanfacine hydrochloride 4mg extended release tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guanfacine hydrochloride	Inferred relationship	Some
Guanfacine hydrochloride 3mg extended release tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guanfacine hydrochloride	Inferred relationship	Some
Guanfacine hydrochloride 1mg extended release tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guanfacine hydrochloride	Inferred relationship	Some
Guanfacine hydrochloride 2mg extended release tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guanfacine hydrochloride	Inferred relationship	Some
Product containing precisely guanfacine hydrochloride 1 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guanfacine hydrochloride	Inferred relationship	Some	1
Product containing precisely guanfacine hydrochloride 1 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Guanfacine hydrochloride	Inferred relationship	Some	1
Product containing precisely guanfacine hydrochloride 2 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guanfacine hydrochloride	Inferred relationship	Some	1
Product containing precisely guanfacine hydrochloride 2 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Guanfacine hydrochloride	Inferred relationship	Some	1
Product containing precisely guanfacine hydrochloride 1 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Guanfacine hydrochloride	Inferred relationship	Some	1
Product containing precisely guanfacine hydrochloride 2 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Guanfacine hydrochloride	Inferred relationship	Some	1
Guanfacine (as guanfacine hydrochloride) 1 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guanfacine hydrochloride	Inferred relationship	Some	1
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guanfacine hydrochloride	Inferred relationship	Some	1
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guanfacine hydrochloride	Inferred relationship	Some	1
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guanfacine hydrochloride	Inferred relationship	Some	1
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guanfacine hydrochloride	Inferred relationship	Some	1
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guanfacine hydrochloride	Inferred relationship	Some	1

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
173088019	Guanfacine hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
602062010	Guanfacine hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
25211000188118	guanfacine chlorhydrate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
815481000172116	chlorhydrate de guanfacine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module